Sensus Healthcare (SRTS) Cash from Financing Activities (2017 - 2025)
Sensus Healthcare (SRTS) recorded quarterly Cash from Financing Activities of -$5000.0 in Q4 2025, up 98.33% quarter-over-quarter from -$300000.0 in Q1 2025, and down 117.86% on a YoY basis from $28000.0 in Q4 2024.
Sensus Healthcare (SRTS) Cash from Financing Activities (2017 - 2025) Analysis & Trends
Sensus Healthcare's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$5000.0 for Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 117.86% year-over-year to -$5000.0; the TTM figure through Dec 2025 stood at -$305000.0 (down 535.42% YoY), while the FY2025 annual figure was -$305000.0, down 2133.33% from the prior year.
- Cash from Financing Activities was -$5000.0 for Q4 2025 at Sensus Healthcare, up from -$300000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $273000.0 in Q1 2022 to a low of -$1.9 million in Q4 2022.
- Historically, Cash from Financing Activities has averaged -$200400.0 across 5 years, with a median of -$39000.0 in 2023.
- Biggest YoY gain for Cash from Financing Activities was 555.0% in 2022; the steepest drop was 3481.48% in 2022.
- A 5-year view of Cash from Financing Activities shows it stood at -$54000.0 in 2021, then sank by 3481.48% to -$1.9 million in 2022, then surged by 99.64% to -$7000.0 in 2023, then jumped by 500.0% to $28000.0 in 2024, then slumped by 117.86% to -$5000.0 in 2025.
- The last three Cash from Financing Activities figures came in at -$5000.0 (Q4 2025), -$300000.0 (Q1 2025), and $28000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Sensus Healthcare | 45.77 Mn | 27.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -300,000.00 |
| Mar 31, 2025 | -300,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | -39,000.00 |
| Sep 30, 2023 | -39,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | -1.93 Mn |
| Dec 31, 2022 | -1.93 Mn |
| Sep 30, 2022 | 211,000.00 |
| Sep 30, 2022 | 211,000.00 |
| Jun 30, 2022 | -978,000.00 |
| Jun 30, 2022 | -978,000.00 |